NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Montpellier

About this trial

The main objective of this study is to compare two independent groups of patients requiring lung biopsy for undetermined interstitial lung disease (ILD) in terms of diagnostic confidence as determined by histologists.

Eligibility criteria

Qualifiers

Patient with purported interstitial lung disease

Patient requiring a surgical lung biopsy to reinforce diagnosis according to current recommendations and validated by a multidisciplinary assessment

Minimum age: 18 years

Disqualifiers

Contra-indication for surgery

Uncontrolled oesophageal gastric reflux despite optimal treatment

Thoracic deformation (For example, pectus excavatum/carinatum or major scoliosis)

Risk of pleural adhesion (For example, patient who has already undergone thoracic surgery)

Trial design

Treatments tested in this trial

  • Non-intubated video-assisted thoracic surgery (NIVATS) for lung biopsy
  • Intubated general anaesthesia video-assisted thoracic surgery (IGAVATS) for lung biopsy

Treatment groups

24 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University Hospital, Montpellier

Lead sponsor

Grace Asso (Groupe francophone de Réhabilitation Améliorée après Chirurgie)

Collaborator